ロード中...
Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
BACKGROUND: Multiple sclerosis (MS) is a heterogeneous disease. In order to understand the partial responsiveness to IFNß in Relapsing Remitting MS (RRMS) we studied the pharmacological effects of IFNß therapy. METHODOLOGY: Large scale gene expression profiling was performed on peripheral blood of 1...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2008
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2271130/ https://ncbi.nlm.nih.gov/pubmed/18382694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0001927 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|